Skip to main content
Article
A comprehensive initiative to optimize accrual to neuro oncology clinical trials.
Journal of Clinical Oncology (2018)
  • Mathew England Grubman, St. John's University
  • Marlon G. Saria, University of California, San Diego
  • Minhdan Nguyen, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Judy Trong, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Najee Boucher, John Wayne Cancer Institute, Santa Monica, CA;
  • Jaya Gill, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Anne Heng, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Anand A Moses, John Wayne Cancer Institute, Santa Monica, CA;
  • Tiffany Juarez, John Wayne Cancer Institute, Santa Monica, CA;
  • Achal Achrol, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Steven O'Day, John Wayne Cancer Institute, Santa Monica, CA;
  • Garni Barkhoudarian, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Daniel F. Kelly, Pacific Neuroscience Institute and John Wayne Cancer Institute at Providence, Saint John’s Health Center, Santa Monica, CA;
  • Santosh Kesari, University of California, San Diego
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.e18546
Citation Information
Mathew England Grubman, Marlon G. Saria, Minhdan Nguyen, Judy Trong, et al.. "A comprehensive initiative to optimize accrual to neuro oncology clinical trials." Journal of Clinical Oncology Vol. 36 (2018)
Available at: http://works.bepress.com/achalsingh-achrol/4/